- Home
- ICAD vs THTX Comparison
ICAD vs THTX Comparison
Compare ICAD & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- THTX
- Stock Information
- Founded
- ICAD 1984
- THTX 1993
- Country
- ICAD United States
- THTX Canada
- Employees
- ICAD N/A
- THTX N/A
- Industry
- ICAD Medical/Dental Instruments
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- THTX Health Care
- Exchange
- ICAD Nasdaq
- THTX Nasdaq
- Market Cap
- ICAD 103.3M
- THTX 119.1M
- IPO Year
- ICAD 1986
- THTX N/A
- Fundamental
- Price
- ICAD $3.81
- THTX $3.15
- Analyst Decision
- ICAD Hold
- THTX Hold
- Analyst Count
- ICAD 1
- THTX 1
- Target Price
- ICAD N/A
- THTX N/A
- AVG Volume (30 Days)
- ICAD 171.1K
- THTX 1.0M
- Earning Date
- ICAD 08-12-2025
- THTX 07-09-2025
- Dividend Yield
- ICAD N/A
- THTX N/A
- EPS Growth
- ICAD N/A
- THTX N/A
- EPS
- ICAD N/A
- THTX N/A
- Revenue
- ICAD $19,528,000.00
- THTX $84,378,000.00
- Revenue This Year
- ICAD $3.60
- THTX N/A
- Revenue Next Year
- ICAD N/A
- THTX $15.13
- P/E Ratio
- ICAD N/A
- THTX N/A
- Revenue Growth
- ICAD 8.86
- THTX 2.19
- 52 Week Low
- ICAD $1.19
- THTX $1.12
- 52 Week High
- ICAD $4.02
- THTX $3.20
- Technical
- Relative Strength Index (RSI)
- ICAD 57.70
- THTX 73.35
- Support Level
- ICAD $3.68
- THTX $2.28
- Resistance Level
- ICAD $3.86
- THTX $3.20
- Average True Range (ATR)
- ICAD 0.14
- THTX 0.07
- MACD
- ICAD -0.00
- THTX 0.07
- Stochastic Oscillator
- ICAD 83.80
- THTX 94.79
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.